MQS Management’s Health Catalyst HCAT Stock Holding History

MQS Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,416	Closed	-$161K	–	555
2023 Q4	$161K	Buy	17,416 +5,927	+52%	+$48.4K	0.09%	394
2023 Q3	$116K	Buy	+11,489	New	+$137K	0.07%	391

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MQS Management's HCAT Position: Q1 2024 in Review

MQS Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 17,416 shares — an estimated $161K sold.

MQS Management first reported a position in HCAT in Q3 2023 and held it in 2 quarters. The position peaked at $161K in Q4 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

MQS Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
MQS Management sold 17,416 Health Catalyst shares in Q1 2024, an estimated $161K.
MQS Management first reported a position in Health Catalyst in Q3 2023 and held it in 2 quarters.
MQS Management's Health Catalyst position peaked at $161K in Q4 2023.
174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on MQS Management's 13F filing for Q1 2024, filed 14 May 2024.